Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
ID: 356920Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)" aimed at supporting studies that identify, develop, and test strategies to overcome barriers to the adoption and sustainability of evidence-based health interventions. The initiative encourages applications that promote equitable dissemination among underrepresented communities and address the de-implementation of ineffective practices, with a focus on innovative strategies for embedding these approaches into clinical and community settings. Interested applicants, including various educational institutions and community organizations, can submit proposals through the R21 Exploratory/Developmental Research Grant mechanism, with applications due by January 7, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-143.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Notice of Funding Opportunity (NOFO) from the Department of Health and Human Services focuses on advancing dissemination and implementation research to overcome barriers associated with evidence-based health interventions. The National Institutes of Health (NIH) encourages applications that support equitable dissemination among underrepresented communities and address the need for de-implementation of ineffective practices. Applicants can seek funding through the R21 Exploratory/Developmental Research Grant mechanism, with studies highlighting innovative strategies for embedding evidence-based approaches into clinical and community settings. Key research areas include pilot testing implementation strategies, economic evaluations, understanding information dissemination dynamics, and developing novel methodologies. The NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity and diverse viewpoints in research processes, emphasizing the importance of multidisciplinary collaboration. The overall goals include reducing cancer prevalence and improving survivor quality of life through effective integration of research findings into practice. Applications are due by specific dates in 2025 through established electronic systems, emphasizing adherence to submission guidelines for successful evaluation.
    Similar Opportunities
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)," aimed at supporting studies that address barriers to the adoption and sustainability of evidence-based health interventions, particularly in underserved communities. The initiative encourages research that promotes equitable access to effective practices and explores methods for discontinuing ineffective or harmful interventions, emphasizing the importance of contextual factors and multidisciplinary collaboration. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $275,000 and a project period of up to two years. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by May 7, 2025.
    Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)" aimed at supporting research that enhances the adoption and implementation of evidence-based health interventions. The initiative focuses on overcoming barriers to the dissemination of these interventions, particularly in underrepresented communities, and encourages studies that explore when to discontinue ineffective practices. This grant is crucial for advancing health equity and improving community health outcomes through multidisciplinary collaboration and innovative research methodologies. Interested applicants can find more information and guidelines at the NIH grants website, with proposals due by January 7, 2028, and a maximum project period of five years. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for "Dissemination and Implementation Research in Health" (R03), aimed at supporting studies that identify and address barriers to the adoption and integration of evidence-based health interventions, particularly among underrepresented communities. This initiative emphasizes the importance of both dissemination research, which focuses on distributing health information, and implementation research, which examines the practical deployment of strategies. Eligible organizations can apply for grants of up to $50,000 for a project period of up to two years, with a requirement to submit a "Plan for Enhancing Diverse Perspectives" to promote inclusivity in research efforts. The application deadline is January 16, 2025, and interested parties can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-233.html.
    Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)" aimed at supporting research that addresses barriers to the adoption and sustainability of evidence-based health interventions. The initiative encourages studies that promote equitable dissemination among underrepresented communities and explore the de-implementation of ineffective practices, emphasizing the importance of interdisciplinary collaboration and stakeholder engagement. Eligible applicants include a wide range of entities such as educational institutions, nonprofits, and government organizations, with funding amounts determined by NIH appropriations and the quality of applications. The application deadline is May 7, 2025, and interested parties can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) grant, aimed at supporting studies that identify and test strategies to enhance the adoption and sustainability of evidence-based health interventions, particularly in underrepresented communities. The initiative focuses on overcoming barriers to the integration of these practices in healthcare settings while promoting equity in health outcomes, encouraging research that addresses both the effectiveness of health interventions and the dissemination strategies necessary for broad implementation. Eligible organizations include higher education institutions, nonprofits, and local governments, with grants of up to $50,000 per year available for a maximum of two years. Interested applicants must submit their proposals by May 7, 2025, and can find additional information and application instructions at http://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html, or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Community Level Interventions to Improve Minority Health and Reduce Health Disparities" (R01 - Clinical Trial Optional), aimed at supporting research that develops and tests community-level interventions to enhance minority health and mitigate health disparities. Applicants are encouraged to form collaborative partnerships with community organizations and must focus on innovative, sustainable initiatives that address health disparities through community-level determinants, employing a conceptual model to connect interventions with health outcomes. The grant provides up to $1 million in direct costs per year for a project duration of up to five years, with applications due by January 7, 2027. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-231.html.
    NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) to support innovative research projects at the preliminary or conceptual stage, particularly those with the potential to advance biomedical, behavioral, or clinical research. Applicants must include at least one clinical trial in their proposals, focusing on mechanistic studies that align with the scientific missions of participating NIH Institutes and Centers. This funding opportunity is crucial for stimulating novel research that challenges conventional methods and improves clinical practices, with a maximum budget of $275,000 available for a two-year project, and no more than $200,000 allocated in any single year. Interested applicants should adhere to strict submission guidelines and can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance; the application deadline is January 7, 2025.
    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) to support innovative research projects in the early stages that can lead to significant advancements in biomedical, behavioral, and clinical research. This funding opportunity requires applicants to propose at least one clinical trial and is aimed at addressing critical gaps in knowledge within the scientific missions of participating NIH Institutes and Centers. Eligible applicants include a diverse range of organizations, such as higher education institutions, nonprofits, and foreign entities, with a total project period limited to two years and a budget of up to $275,000. The application period opens on January 16, 2025, and closes on January 8, 2028; interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)" aimed at investigating the biological and genetic mechanisms underlying cancer health disparities among diverse racial and ethnic populations. This funding initiative encourages innovative pilot studies that focus on identifying cancer risk factors, developing preventative strategies, and enhancing research methodologies, while fostering a multidisciplinary cohort dedicated to cancer health disparities research. Eligible applicants include a wide range of entities such as educational institutions, nonprofits, and tribal organizations, with a maximum funding amount of $275,000 available for a two-year project period. Interested parties should note that the application deadline is November 16, 2027, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-244.html for further details.